Journal
BIOMARKERS IN MEDICINE
Volume 1, Issue 1, Pages 159-185Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17520363.1.1.159
Keywords
-
Categories
Funding
- NCRR NIH HHS [P41 RR018522, P41 RR018522-04] Funding Source: Medline
- NIDDK NIH HHS [R33 DK071283, R21 DK071283, R33 DK070146, R21 DK071283-02, R33 DK070146-03] Funding Source: Medline
Ask authors/readers for more resources
The future utility of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery is discussed, beginning with a brief description of the evolution of metabolomics and the utilization of the three most popular analytical platforms in such studies: nuclear magnetic resonance, gas chromatography-MS and LC-MS. Emphasis is placed on recent developments in high-efficiency LC separations, sensitive electrospray ionization approaches and the benefits of incorporating both in LC-MS-based approaches. The advantages and disadvantages of various quantitative approaches are reviewed, followed by the current LC-MS-based tools available for candidate biomarker characterization and identification. Finally, a brief prediction on the future path of LC-MS-based methods in metabolic profiling and metabolomic studies is given.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available